Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
Research output: Contribution to conference › Paper
Standard Standard
Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective? / Hughes, D.; Hughes, D.A.; Pirmohamed, M.
2003. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain.
2003. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain.
Research output: Contribution to conference › Paper
HarvardHarvard
Hughes, D, Hughes, DA & Pirmohamed, M 2003, 'Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?', Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain, 3/01/01.
APA
Hughes, D., Hughes, D. A., & Pirmohamed, M. (2003). Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain.
CBE
Hughes D, Hughes DA, Pirmohamed M. 2003. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain.
MLA
Hughes, D., D.A. Hughes and M. Pirmohamed Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain, 03 Jan 0001, Paper, 2003.
VancouverVancouver
Hughes D, Hughes DA, Pirmohamed M. Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?. 2003. Paper presented at International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain.
Author
RIS
TY - CONF
T1 - Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
AU - Hughes, D.
AU - Hughes, D.A.
AU - Pirmohamed, M.
PY - 2003/11/1
Y1 - 2003/11/1
M3 - Paper
T2 - International Society for Pharmacoeconomics and Outcomes Research, Barcelona, Spain
Y2 - 3 January 0001
ER -